Ustekinumab in the therapy of chronic plaque psoriasis
Jenna L O’Neill, Robert E KalbState University of New York at Buffalo, School of Medicine and Biomedical Sciences, Department of Dermatology, NY, USAAbstract: Psoriasis is a chronic inflammatory disorder characterized by T cell dysregulation and a chronic inflammatory infiltrate within...
Enregistré dans:
Auteurs principaux: | Jenna L O’Neill, Robert E Kalb |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4b41c48fa8894b93843f32c8ef6c87df |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
par: Santo Raffaele Mercuri, et autres
Publié: (2010) -
Infliximab for the treatment of plaque psoriasis
par: Jennifer S Gall, et autres
Publié: (2008) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
par: Matsumoto S, et autres
Publié: (2018) -
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
par: Hampton P, et autres
Publié: (2021) -
Biological drugs targeting the immune response in the therapy of psoriasis
par: Saveria Pastore, et autres
Publié: (2008)